Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/4985 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2450740

The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

L'invention a trait à des composés inhibiteurs de la dipeptidyl peptidase IV ("inhibiteurs DP-IV ") qui sont utiles dans le traitement ou dans la prévention des maladies dans lesquelles est impliquée dipeptidyl peptidase IV, telles que le diabète et notamment le diabète de type 2. L'invention a également trait à des compositions pharmaceutiques comprenant ces composés et à l'utilisation de ces composés et compositions dans la prévention ou dans le traitement de ces maladies dans lesquelles dipeptidyl peptidase IV est impliquée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1515279

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.